Updated:
MDBriefCase Group Inc.
MDBriefCase Group Inc. runs an online continuing medical education (CME) platform for physicians, nurses, and allied health professionals.
MDBriefCase Group Inc.
MDBriefCase Group Inc. runs an online continuing medical education (CME) platform for physicians, nurses, and allied health professionals. The company was founded more than 20 years ago and has accumulated over 285,000 registered users worldwide. Its headquarters are in Toronto, Canada, and it localizes content for Canadian, Australian, and Middle Eastern markets. The platform generates revenue primarily through sponsorship from pharmaceutical and medical-device companies that fund course development. Courses cover therapeutic areas including cardiovascular disease, diabetes, oncology, dermatology, mental health, and infectious disease. MDBriefCase offers courses in both English and French, with content categorized by accreditation type including Mainpro+ and MOC-Section 3. The company partners with global leaders in medical education, though specific partner names are not disclosed on its public website. MDBriefCase employs no publicly listed investment team or asset management structure. There is no disclosed AUM, deployment activity, or investment portfolio. The company does not appear to operate as a traditional family office, asset manager, or fund vehicle. Its organizational structure and ownership remain undisclosed in public records. The company’s structural differentiator lies in its business model — it serves as a regulated CME/CPD provider that derives funding from commercial sponsors while maintaining peer-reviewed clinical content. This creates a dual-ended marketplace: healthcare professionals receive free accredited education, and life-science sponsors access a targeted, engaged physician audience.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, ON, Canada
Sector focus
Frequently asked questions
Who runs investment decisions at MDBriefCase Group?
MDBriefCase Group does not publicly disclose its leadership or investment team. No named principals or investment committee members are listed on the company's website or in public records.
How does MDBriefCase generate revenue?
MDBriefCase operates a sponsor-supported platform where pharmaceutical and medical-device companies fund the development of continuing medical education courses. Courses are free to healthcare professionals, and the company collects sponsorship fees from commercial partners.
Is MDBriefCase structured as a family office or an operating company?
MDBriefCase Group Inc. does not present itself as a family office or investment vehicle. It is an operating company that delivers accredited medical education. There is no public evidence of asset management, fund commitments, or direct investment activity.
Does MDBriefCase participate in fund commitments or direct deals?
No. MDBriefCase Group is not known to commit capital to external funds or engage in direct investments. Its disclosed activities are limited to operating a CME/CPD platform.
What investment stages does MDBriefCase typically target?
MDBriefCase Group does not target any investment stages. Its business is the production and distribution of continuing medical education content, not capital deployment.
Which sectors does MDBriefCase explicitly avoid?
MDBriefCase does not publicly disclose any exclusionary sectors. Its course offerings focus exclusively on healthcare and medical topics, with no presence in other industries.
What is MDBriefCase's known posture on co-investments alongside external GPs?
MDBriefCase Group has no disclosed posture on co-investments. It is not an investment manager or family office, and no co-investment activity is publicly recorded.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: